Exome data clouds the pathogenicity of genetic variants in Pulmonary Arterial Hypertension

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Exome data clouds the pathogenicity of genetic variants in Pulmonary Arterial Hypertension. / Abbasi, Yeganeh; Jabbari, Javad; Jabbari, Reza; Glinge, Charlotte; Izadyar, Seyed Bahador; Spiekerkoetter, Edda; Zamanian, Roham T.; Carlsen, Jørn; Tfelt-Hansen, Jacob.

In: Molecular Genetics and Genomic Medicine, Vol. 6, No. 5, 01.09.2018, p. 835-844.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Abbasi, Y, Jabbari, J, Jabbari, R, Glinge, C, Izadyar, SB, Spiekerkoetter, E, Zamanian, RT, Carlsen, J & Tfelt-Hansen, J 2018, 'Exome data clouds the pathogenicity of genetic variants in Pulmonary Arterial Hypertension', Molecular Genetics and Genomic Medicine, vol. 6, no. 5, pp. 835-844. https://doi.org/10.1002/mgg3.452

APA

Abbasi, Y., Jabbari, J., Jabbari, R., Glinge, C., Izadyar, SB., Spiekerkoetter, E., Zamanian, R. T., Carlsen, J., & Tfelt-Hansen, J. (2018). Exome data clouds the pathogenicity of genetic variants in Pulmonary Arterial Hypertension. Molecular Genetics and Genomic Medicine, 6(5), 835-844. https://doi.org/10.1002/mgg3.452

Vancouver

Abbasi Y, Jabbari J, Jabbari R, Glinge C, Izadyar SB, Spiekerkoetter E et al. Exome data clouds the pathogenicity of genetic variants in Pulmonary Arterial Hypertension. Molecular Genetics and Genomic Medicine. 2018 Sep 1;6(5):835-844. https://doi.org/10.1002/mgg3.452

Author

Abbasi, Yeganeh ; Jabbari, Javad ; Jabbari, Reza ; Glinge, Charlotte ; Izadyar, Seyed Bahador ; Spiekerkoetter, Edda ; Zamanian, Roham T. ; Carlsen, Jørn ; Tfelt-Hansen, Jacob. / Exome data clouds the pathogenicity of genetic variants in Pulmonary Arterial Hypertension. In: Molecular Genetics and Genomic Medicine. 2018 ; Vol. 6, No. 5. pp. 835-844.

Bibtex

@article{8b40c9a95fe942a8a662102c2ca52c6b,
title = "Exome data clouds the pathogenicity of genetic variants in Pulmonary Arterial Hypertension",
abstract = "Background: We aimed to provide a set of previously reported PAH-associated missense and nonsense variants, and evaluate the pathogenicity of those variants. Methods: The Human Gene Mutation Database, PubMed, and Google Scholar were searched for previously reported PAH-associated genes and variants. Thereafter, both exome sequencing project and exome aggregation consortium as background population searched for previously reported PAH-associated missense and nonsense variants. The pathogenicity of previously reported PAH-associated missense variants evaluated by using four in silico prediction tools. Results: In total, 14 PAH-associated genes and 180 missense and nonsense variants were gathered. The BMPR2, the most frequent reported gene, encompasses 135 of 180 missense and nonsense variants. The exome sequencing project comprised 9, and the exome aggregation consortium counted 25 of 180 PAH-associated missense and nonsense variants. The TOPBP1 and ENG genes are unlikely to be the monogenic cause of PAH pathogenesis based on allele frequency in background population and prediction analysis. Conclusion: This is the first evaluation of previously reported PAH-associated missense and nonsense variants. The BMPR2 identified as the major gene out of 14 PAH-associated genes. Based on findings, the ENG and TOPBP1 gene are not likely to be the monogenic cause of PAH.",
keywords = "ESP, exome sequencing project, HGMD, PAH-associated gene, pulmonary arterial hypertension",
author = "Yeganeh Abbasi and Javad Jabbari and Reza Jabbari and Charlotte Glinge and Seyed Bahador Izadyar and Edda Spiekerkoetter and Zamanian, {Roham T.} and J{\o}rn Carlsen and Jacob Tfelt-Hansen",
year = "2018",
month = sep,
day = "1",
doi = "10.1002/mgg3.452",
language = "English",
volume = "6",
pages = "835--844",
journal = "Molecular genetics & genomic medicine",
issn = "2324-9269",
publisher = "JohnWiley & Sons Ltd",
number = "5",

}

RIS

TY - JOUR

T1 - Exome data clouds the pathogenicity of genetic variants in Pulmonary Arterial Hypertension

AU - Abbasi, Yeganeh

AU - Jabbari, Javad

AU - Jabbari, Reza

AU - Glinge, Charlotte

AU - Izadyar, Seyed Bahador

AU - Spiekerkoetter, Edda

AU - Zamanian, Roham T.

AU - Carlsen, Jørn

AU - Tfelt-Hansen, Jacob

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Background: We aimed to provide a set of previously reported PAH-associated missense and nonsense variants, and evaluate the pathogenicity of those variants. Methods: The Human Gene Mutation Database, PubMed, and Google Scholar were searched for previously reported PAH-associated genes and variants. Thereafter, both exome sequencing project and exome aggregation consortium as background population searched for previously reported PAH-associated missense and nonsense variants. The pathogenicity of previously reported PAH-associated missense variants evaluated by using four in silico prediction tools. Results: In total, 14 PAH-associated genes and 180 missense and nonsense variants were gathered. The BMPR2, the most frequent reported gene, encompasses 135 of 180 missense and nonsense variants. The exome sequencing project comprised 9, and the exome aggregation consortium counted 25 of 180 PAH-associated missense and nonsense variants. The TOPBP1 and ENG genes are unlikely to be the monogenic cause of PAH pathogenesis based on allele frequency in background population and prediction analysis. Conclusion: This is the first evaluation of previously reported PAH-associated missense and nonsense variants. The BMPR2 identified as the major gene out of 14 PAH-associated genes. Based on findings, the ENG and TOPBP1 gene are not likely to be the monogenic cause of PAH.

AB - Background: We aimed to provide a set of previously reported PAH-associated missense and nonsense variants, and evaluate the pathogenicity of those variants. Methods: The Human Gene Mutation Database, PubMed, and Google Scholar were searched for previously reported PAH-associated genes and variants. Thereafter, both exome sequencing project and exome aggregation consortium as background population searched for previously reported PAH-associated missense and nonsense variants. The pathogenicity of previously reported PAH-associated missense variants evaluated by using four in silico prediction tools. Results: In total, 14 PAH-associated genes and 180 missense and nonsense variants were gathered. The BMPR2, the most frequent reported gene, encompasses 135 of 180 missense and nonsense variants. The exome sequencing project comprised 9, and the exome aggregation consortium counted 25 of 180 PAH-associated missense and nonsense variants. The TOPBP1 and ENG genes are unlikely to be the monogenic cause of PAH pathogenesis based on allele frequency in background population and prediction analysis. Conclusion: This is the first evaluation of previously reported PAH-associated missense and nonsense variants. The BMPR2 identified as the major gene out of 14 PAH-associated genes. Based on findings, the ENG and TOPBP1 gene are not likely to be the monogenic cause of PAH.

KW - ESP

KW - exome sequencing project

KW - HGMD

KW - PAH-associated gene

KW - pulmonary arterial hypertension

UR - http://www.scopus.com/inward/record.url?scp=85052646997&partnerID=8YFLogxK

U2 - 10.1002/mgg3.452

DO - 10.1002/mgg3.452

M3 - Journal article

C2 - 30084161

AN - SCOPUS:85052646997

VL - 6

SP - 835

EP - 844

JO - Molecular genetics & genomic medicine

JF - Molecular genetics & genomic medicine

SN - 2324-9269

IS - 5

ER -

ID: 203555441